Related Experiment Video
Updated: Jul 30, 2026

09:51
Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression
Published on: March 5, 2013
TSH receptor gene expression in retroocular fibroblasts
M Mengistu1, Y G Lukes, E V Nagy
1Kyle Metabolic Unit, Department of Medicine, Walter Reed Army Medical Center, Washington, D.C. 20307-5001.
Journal of Endocrinological Investigation
|June 1, 1994
Summary
Human fibroblasts express the human thyroid-stimulating hormone receptor (hTSH-R). This suggests that immune responses targeting these fibroblast TSH receptors may contribute to Graves' ophthalmopathy.
Area of Science:
- Endocrinology
- Immunology
- Molecular Biology
Background:
- Graves' ophthalmopathy is an autoimmune condition affecting the eye.
- The role of fibroblasts in the pathogenesis of Graves' ophthalmopathy is not fully understood.
- The human thyroid-stimulating hormone receptor (hTSH-R) is a key autoantigen in Graves' disease.
Purpose of the Study:
- To investigate the expression of hTSH-R in human fibroblasts from different anatomical locations.
- To explore the potential role of fibroblast-expressed hTSH-R in the immune response associated with Graves' ophthalmopathy.
Main Methods:
- RNA isolation from retroocular, orbital, and abdominal skin fibroblasts.
- Reverse transcription of RNA to cDNA.
- Polymerase Chain Reaction (PCR) using primers for the extracellular domain of hTSH-R.
- Ethidium bromide staining and hybridization for product confirmation.
Main Results:
- A 247 base pair (BP) product, homologous to hTSH-R cDNA, was detected in fibroblast RNA.
- hTSH-R expression was confirmed in fibroblasts from all tested locations.
- These findings indicate the presence of functional hTSH-R in human fibroblasts.
Conclusions:
- Human fibroblasts express hTSH-R.
- Cross-reactivity between anti-hTSH-R antibodies and fibroblast TSH receptors may contribute to Graves' ophthalmopathy development.
- Fibroblast hTSH-R represents a potential target in the autoimmune process of Graves' ophthalmopathy.

